SCHEMBL5696151

SCHEMBL5696151

O=C(Nc1ccc([N+](=O)[O-])cc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 1.00
KMT2A Q03164 7/20 1.00
NPC1 O15118 4/20 1.00
RAB9A P51151 4/20 1.00
MITF O75030 2/20 1.00
POLB P06746 2/20 1.00
ALOX5 P09917 1/20 0.69
FFAR1 O14842 1/20 0.64
MAPT P10636 3/20 0.64
MAPK1 P28482 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.63
PTPN1 P18031 1/20 0.62
HTT P42858 1/20 0.62
P4HTM Q9NXG6 1/20 0.61
ATM Q13315 1/20 0.61
CD40 P25942 1/20 0.61
CD40LG P29965 1/20 0.61
SIRT1 Q96EB6 1/20 0.61
CES2 O00748 1/20 0.61
CES1 P23141 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27362324 0.98 MEN1 (0.97) MEN1KMT2ANPC1RAB9AMITF
Iodide SCHEMBL30758586 0.98 MEN1 (0.97) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL3160310 0.93 MEN1 (0.87) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL23898948 0.91 KMT2A (0.83) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL9134339 0.91 KMT2A (0.83) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL8572381 0.91 KMT2A (0.83) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL12218318 0.91 MEN1 (0.82) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL7881346 0.88 KMT2A (0.79) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL7696438 0.88 KMT2A (0.79) MEN1KMT2ANPC1RAB9AMITF
SCHEMBL6855014 0.88 KMT2A (0.79) MEN1KMT2ANPC1RAB9AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021151104-A1 SALICYLAMIDE DERIVATIVES AND RELATED METHODS OF MAKING THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-07-29 WO claimed
US-20200231550-A1 COMPOUNDS FOR TREATING TUBERCULOSIS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2020-07-23 US claimed
WO-2018151681-A1 COMPOUNDS FOR TREATING TUBERCULOSIS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2018-08-23 WO claimed
US-20130267712-A1 AROMATIC KETONE SYNTHESIS WITH AMIDE REAGENTS AND RELATED REACTIONS BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY (US) 2013-10-10 US claimed
US-20260125340-A1 METHOD FOR PREPARING AMIDES FROM ESTERS BASF SE (DE) 2026-05-07 US disclosed
EP-4598900-A1 METHOD FOR PREPARING AMIDES FROM ESTERS BASF SE (DE) 2025-08-13 EP disclosed
CN-119998260-A Process for preparing amides from esters 巴斯夫欧洲公司 2025-05-13 CN disclosed
CN-118048636-B Electrocatalytic synthesis method for N-aryl amide 平顶山学院 2024-09-13 CN disclosed
CN-118048636-A Electrocatalytic synthesis method for N-aryl amide 平顶山学院 2024-05-17 CN disclosed
WO-2024074641-A1 METHOD FOR PREPARING AMIDES FROM ESTERS BASF SE (DE) 2024-04-11 WO disclosed
US-11078165-B2 Compounds for treating tuberculosis NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2021-08-03 US disclosed
US-11078165-B2 Compounds for treating tuberculosis NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2021-08-03 US disclosed
CN-1098402-A Preparation method and product thereof to the nitryl aromatic acid amides MONSANTO CO (US) 1995-02-08 CN disclosed
US-5380946-A From nitrobenzene and a nitrile MONSANTO COMPANY (US) 1995-01-10 US disclosed
US-5331099-A Process for preparing p-nitroaromatic amides and products thereof MONSANTO COMPANY (US) 1994-07-19 US disclosed
WO-1994008953-A1 PROCESS FOR PREPARING ISOCYANATE AND CARBAMATE ESTER PRODUCTS MONSANTO COMPANY (US) 1994-04-28 WO disclosed
WO-1993024447-A1 PROCESS FOR PREPARING P-NITROAROMATIC AMIDES AND PRODUCTS THEREOF MONSANTO COMPANY (US) 1993-12-09 WO disclosed
US-5233010-A Reacting carbon dioxide and an aromatic diamine in an aprotic solvent and a base to produce a carbamate salt; dehydration; reacting an amide with nitrobenzene and reducing to obtain the amine MONSANTO COMPANY (US) 1993-08-03 US disclosed
US-4499167-A Photoconductive compositions comprising an organic photoconductor and an amide compound and electro-photographic light-sensitive materials using the compositions FUJI PHOTO FILM CO., LTD. (JP) 1985-02-12 US disclosed
EP-0065395-A2 Improved chymopapain and method for its production and use BOOTS-FLINT, INC. (a Delaware corp.) (US) 1982-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260125340-A1 METHOD FOR PREPARING AMIDES FROM ESTERS CBR1, CBR3, SCO2 MEN1 2007/4885KMT2A 1928/4885NPC1 549/4885
US-11078165-B2 Compounds for treating tuberculosis ATP5ME, ATP5MG, ATP5F1D MEN1 4589/4885KMT2A 2920/4885NPC1 1580/4885
US-20200231550-A1 COMPOUNDS FOR TREATING TUBERCULOSIS ATP5ME, ATP5MG, ATP5F1D MEN1 4589/4885KMT2A 2920/4885NPC1 1580/4885
US-20130267712-A1 AROMATIC KETONE SYNTHESIS WITH AMIDE REAGENTS AND RELATED REACTIONS NAAA, AADAC, NISCH MEN1 4420/4885KMT2A 261/4885NPC1 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.